Litronesib Terminated Phase 1 Trials for Leukemia, Acute Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01214655A Study for Patients With Acute Leukemia